152 related articles for article (PubMed ID: 33977099)
21. Evolutionary gain of function for the ER membrane protein Sec62 from yeast to humans.
Müller L; de Escauriaza MD; Lajoie P; Theis M; Jung M; Müller A; Burgard C; Greiner M; Snapp EL; Dudek J; Zimmermann R
Mol Biol Cell; 2010 Mar; 21(5):691-703. PubMed ID: 20071467
[TBL] [Abstract][Full Text] [Related]
22. Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia.
Meng Y; Zhao H; Zhao Z; Yin Z; Chen Z; Du J
Cell Biochem Biophys; 2021 Dec; 79(4):747-755. PubMed ID: 34120320
[TBL] [Abstract][Full Text] [Related]
23. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
[TBL] [Abstract][Full Text] [Related]
24. Mammalian Sec61 is associated with Sec62 and Sec63.
Meyer HA; Grau H; Kraft R; Kostka S; Prehn S; Kalies KU; Hartmann E
J Biol Chem; 2000 May; 275(19):14550-7. PubMed ID: 10799540
[TBL] [Abstract][Full Text] [Related]
25. Effect of the 3q26-coding oncogene
Radosa JC; Kasoha M; Schilz AC; Takacs ZF; Kaya A; Radosa MP; Linxweiler B; Linxweiler M; Bohle RM; Wagner M; Wagenpfeil G; Solomayer EF; Zimmermann JSM
Front Physiol; 2022; 13():1054508. PubMed ID: 36685175
[TBL] [Abstract][Full Text] [Related]
26. Protein transport into the endoplasmic reticulum: mechanisms and pathologies.
Zimmermann R; Müller L; Wullich B
Trends Mol Med; 2006 Dec; 12(12):567-73. PubMed ID: 17071140
[TBL] [Abstract][Full Text] [Related]
27. Expression of 3q oncogene
Müller CSL; Kreie L; Bochen F; Pfuhl T; Smola S; Gräber S; Vogt T; Schick B; Linxweiler M
Oncol Lett; 2019 Feb; 17(2):1768-1776. PubMed ID: 30675236
[TBL] [Abstract][Full Text] [Related]
28. Role of the SEC62 gene in dermato-oncology - impact on tumor cell biology, prognostication, and personalized therapy management.
Linxweiler M; Müller CSL
J Dtsch Dermatol Ges; 2022 Sep; 20(9):1187-1199. PubMed ID: 36067526
[TBL] [Abstract][Full Text] [Related]
29. Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study.
Dugum M; Hanouneh I; McIntyre T; Pai R; Aucejo F; Eghtesad B; Zein N
Mol Clin Oncol; 2016 Mar; 4(3):369-374. PubMed ID: 26998285
[TBL] [Abstract][Full Text] [Related]
30. The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in
Zimmermann JSM; Linxweiler J; Radosa JC; Linxweiler M; Zimmermann R
Front Physiol; 2022; 13():1014271. PubMed ID: 36262254
[TBL] [Abstract][Full Text] [Related]
31. Expression of
Müller CSL; Pföhler C; Wahl M; Bochen F; Körner S; Kühn JP; Bozzato A; Schick B; Linxweiler M
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915997
[No Abstract] [Full Text] [Related]
32. [Characteristic genomics of peripheral blood mononuclear cells of hepatocellular carcinoma patients with liver-kidney yin deficiency syndrome].
Weng L; Du J; He WT; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):406-15. PubMed ID: 22500714
[TBL] [Abstract][Full Text] [Related]
33. Expression of Fibrogenic Markers in Tumor and Tumor-Surrounding Tissue at Time of Transplantation Correlates with Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.
Kocabayoglu P; Piras-Straub K; Gerken G; Paul A; Herzer K
Ann Transplant; 2017 Jul; 22():446-454. PubMed ID: 28729525
[TBL] [Abstract][Full Text] [Related]
34. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Wang Q; Tan YX; Ren YB; Dong LW; Xie ZF; Tang L; Cao D; Zhang WP; Hu HP; Wang HY
BMC Cancer; 2011 Jun; 11():271. PubMed ID: 21702992
[TBL] [Abstract][Full Text] [Related]
35. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
36. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.
Bonnin M; Fares N; Testoni B; Estornes Y; Weber K; Vanbervliet B; Lefrançois L; Garcia A; Kfoury A; Pez F; Coste I; Saintigny P; Viari A; Lang K; Guey B; Hervieu V; Bancel B; Bartoch B; Durantel D; Renno T; Merle P; Lebecque S
J Hepatol; 2019 Oct; 71(4):763-772. PubMed ID: 31220470
[TBL] [Abstract][Full Text] [Related]
38. Extragenic suppressors of mutations in the cytoplasmic C terminus of SEC63 define five genes in Saccharomyces cerevisiae.
Nelson MK; Kurihara T; Silver PA
Genetics; 1993 May; 134(1):159-73. PubMed ID: 8514125
[TBL] [Abstract][Full Text] [Related]
39. Different effects of Sec61α, Sec62 and Sec63 depletion on transport of polypeptides into the endoplasmic reticulum of mammalian cells.
Lang S; Benedix J; Fedeles SV; Schorr S; Schirra C; Schäuble N; Jalal C; Greiner M; Hassdenteufel S; Tatzelt J; Kreutzer B; Edelmann L; Krause E; Rettig J; Somlo S; Zimmermann R; Dudek J
J Cell Sci; 2012 Apr; 125(Pt 8):1958-69. PubMed ID: 22375059
[TBL] [Abstract][Full Text] [Related]
40. Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma.
Wemmert S; Lindner Y; Linxweiler J; Wagenpfeil S; Bohle R; Niewald M; Schick B
Oncol Lett; 2016 Mar; 11(3):1661-1670. PubMed ID: 26998059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
